Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.
Show more...
FAQ
Shanghai Allist Pharmaceuticals 今天的股價是多少?▼
688578.SHG 目前價格為 ¥97.79 CNY,過去 24 小時上漲了 +2.16%。在圖表上更密切關注 Shanghai Allist Pharmaceuticals 股價表現。
Shanghai Allist Pharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Shanghai Allist Pharmaceuticals 的股票以代號 688578.SHG 進行交易。
Shanghai Allist Pharmaceuticals 的市值是多少?▼
今天 Shanghai Allist Pharmaceuticals 的市值為 44.01B
Shanghai Allist Pharmaceuticals 下一次財報日期是什麼時候?▼
Shanghai Allist Pharmaceuticals 將於 April 23, 2026 公布下一次財報。
Shanghai Allist Pharmaceuticals 去年的營收是多少?▼
Shanghai Allist Pharmaceuticals 去年的營收為 7.02BCNY。
Shanghai Allist Pharmaceuticals 去年的淨利是多少?▼
688578.SHG 去年的淨收益為 2.86BCNY。
Shanghai Allist Pharmaceuticals 會發放股息嗎?▼
是的,688578.SHG 的股息每 半年一次 發放一次。每股最新股息為 0.4 CNY。截至今日,股息殖利率(FWD)% 為 0.84%。
Shanghai Allist Pharmaceuticals 有多少名員工?▼
截至 April 22, 2026,公司共有 1,417 名員工。
Shanghai Allist Pharmaceuticals 位於哪個產業?▼
Shanghai Allist Pharmaceuticals從事於Health & Wellness產業。
Shanghai Allist Pharmaceuticals 何時完成拆股?▼
Shanghai Allist Pharmaceuticals 最近沒有進行任何拆股。
Shanghai Allist Pharmaceuticals 的總部在哪裡?▼
Shanghai Allist Pharmaceuticals 的總部位於 中國 的 Shanghai。